References
1. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739-2791.
2. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159-e1195.
3. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231-1243.
4. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. A long-term follow-up study. Circulation.1999;99:1851-1857.
5. Tarasoutchi F, Grinberg M, Spina GS, et al. Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol. 2003;41:1316-1324.
6. Roy DA, Schaefer U, Guetta V, et al. Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation.J Am Coll Cardiol. 2013;61:1577-1584.
7. Testa L, Latib A, Rossi ML, et al. CoreValve implantation for severe aortic regurgitation: a multicentre registry.EuroIntervention. 2014;10:739-745.
8. Zhu D, Chen Y, Zhang J, Hu J, Guo Y. Transapical implantation of a new second-generation transcatheter heart valve in patients with pure aortic regurgitation: a preliminary report.Interact Cardiovasc Thorac Surg. 2015;20:860-862.
9. Liu H, Yang Y, Wang W, et al. Transapical transcatheter aortic valve replacement for aortic regurgitation with a second-generation heart valve. J Thorac Cardiovasc Surg.2018;156:106-116.
10. L L, J Z, Y P, et al. Learning curve for transcatheter aortic valve replacement for native aortic regurgitation: Safety and technical performance study. Clinical cardiology.2020;43:475-482.
11. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.2003;16:777-802.
12. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.2009;22:1-23; quiz 101-102.
13. Kappetein AP, Head SJ, Genereux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33:2403-2418.
14. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography. 2017;30:303-371.
15. Zhu D, Chen W, Peng L, Guo Y. Valve sizing for pure aortic regurgitation during transcatheter aortic valve replacement: deformation dynamic of the aortic annulus in different valve pathology may be different. JACC Cardiovasc Interv. 2015;8:372-373.
16. Seiffert M, Bader R, Kappert U, et al. Initial German experience with transapical implantation of a second-generation transcatheter heart valve for the treatment of aortic regurgitation.JACC Cardiovasc Interv. 2014;7:1168-1174.
17. Kiefer P, Seeburger J, Mohr FW, Holzhey DM. Transcatheter aortic valve replacement for isolated aortic valve insufficiency: experience with the Engager valve. J Thorac Cardiovasc Surg.2014;147:e37-38.
18. Webb JG, Sathananthan J. Transcatheter Aortic Valve Replacement for Pure Noncalcific Aortic Regurgitation Is Coming, But Not Yet Primetime. JACC Cardiovasc Interv. 2016;9:2318-2319.
19. Sawaya FJ, Deutsch MA, Seiffert M, et al. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. JACC Cardiovasc Interv. 2017;10:1048-1056.
20. Yoon S-H, Schmidt T, Bleiziffer S, et al. Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation.Journal of the American College of Cardiology. 2017;70:2752-2763.
21. Spina R, Anthony C, Muller DW, Roy D. Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation.Interventional cardiology (London, England). 2015;10:49-54.
22. B W, S E, EP N, et al. Transcatheter aortic valve replacement for pure aortic valve regurgitation: ”on-label” versus ”off-label” use of TAVR devices. Clinical research in cardiology : official journal of the German Cardiac Society. 2019;108:921-930.
23. Luo X, Wang X, Li X, et al. Transapical transcatheter aortic valve implantation using the J-Valve system: A 1-year follow-up study. J Thorac Cardiovasc Surg. 2017;154:46-55.
24. Rawasia WF, Khan MS, Usman MS, et al. Safety and efficacy of transcatheter aortic valve replacement for native aortic valve regurgitation: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2019;93:345-353.
25. Beckmann A, Funkat AK, Lewandowski J, et al. Cardiac Surgery in Germany during 2014: A Report on Behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg.2015;63:e1.
26. M S, L C, O W, et al. The JUPITER registry: One-year outcomes of transapical aortic valve implantation using a second generation transcatheter heart valve for aortic regurgitation.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.2018;91:1345-1351.
27. A C, V R, S A, J I, T D. Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.2006;29:133-138.
28. Pai RG, Varadarajan P. Prognostic implications of mitral regurgitation in patients with severe aortic regurgitation.Circulation. 2010;122:S43-47.
29. Schofer J, Nietlispach F, Bijuklic K, et al. Transfemoral Implantation of a Fully Repositionable and Retrievable Transcatheter Valve for Noncalcified Pure Aortic Regurgitation. JACC Cardiovasc Interv. 2015;8:1842-1849.
30. Fadahunsi OO, Olowoyeye A, Ukaigwe A, et al. Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry.JACC Cardiovasc Interv. 2016;9:2189-2199.